Skip to Main Content
Legislation Search

H.R. 1262: Give Kids a Chance Act of 2025

The Give Kids a Chance Act of 2025 is designed to improve the investigation and development of drugs specifically for pediatric cancers. Here’s an overview of the main features of the bill:

1. Pediatric Drug Research Enhancement

The bill allows for more comprehensive investigations into the use of existing and new drugs for treating pediatric cancers. This includes:

  • Facilitating clinical trials to gather data on the effectiveness and safety of molecularly targeted cancer therapies in children.
  • Requiring studies to be designed to produce meaningful data that can inform proper dosing and labeling for pediatric patients.

2. Accountability for Pediatric Studies

The legislation strengthens the accountability of pharmaceutical companies to complete pediatric study requirements. This includes:

  • Implementing penalties for companies that do not fulfill their responsibilities regarding pediatric studies.
  • Ensuring that enforcement actions can only be taken if the company is found to have acted without due diligence.

3. Reporting and Compliance

The bill mandates various reporting requirements, such as:

  • The Secretary of Health and Human Services must report on compliance with the new pediatric study requirements.
  • The Government Accountability Office (GAO) will study the effectiveness of these requirements and their impact on drug development for pediatric cancers.

4. Priority Review Vouchers

The legislation extends the existing system of priority review vouchers for treatments developed for rare pediatric diseases until September 30, 2029. This encourages pharmaceutical companies to invest in research and development for these treatments.

5. Limitations on Orphan Drug Exclusivity

It modifies the rules around orphan drug exclusivity, which traditionally grants exclusive rights for seven years. The new amendments prevent companies from claiming exclusivity for drugs that treat the same condition as an already approved drug but are intended for different uses or indications.

6. Program for Pediatric Studies

The bill establishes a specific program that allocates funds for conducting studies on drugs for pediatric populations, specifically designating $25 million per year from 2025 to 2027.

7. Organ Procurement and Transplantation Network Updates

Improvements to the existing Organ Procurement and Transplantation Network, focusing on the integration of technology to streamline organ transplants for pediatric patients, are also included.

8. Establishment of an Office for Abraham Accords

A new office within the Food and Drug Administration (FDA) will focus on enhancing collaboration and regulatory cooperation with countries that are part of the Abraham Accords. This includes sharing information and technical assistance related to drug approval processes.

9. Required Studies and Reporting

The bill mandates studies on the efficacy of priority review vouchers and progress toward regulatory compliance, aiming to improve outcomes for pediatric drug development.

Relevant Companies

  • PFE (Pfizer Inc.): Potentially impacted due to its involvement in oncology research, including pediatric cancer treatments.
  • NVS (Novartis AG): As a major player in pharmaceuticals with a focus on treatments for rare diseases, it may be affected by extended incentives under this bill.
  • AMGN (Amgen Inc.): Might see implications for its studies and treatments relevant to pediatric cancers and rare diseases.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

223 bill sponsors

Actions

2 actions

Date Action
Feb. 12, 2025 Introduced in House
Feb. 12, 2025 Referred to the House Committee on Energy and Commerce.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC
Purchase $1,001 - $15,000
Jul 09, 2025 Jun 20, 2025 -3.25%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC
Purchase $1,001 - $15,000
Jul 09, 2025 Jun 20, 2025 -3.25%
Congress pfp
Cliff Bentz R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 09, 2025 Jun 06, 2025 -3.24%
Congress pfp
Ron Wyden D / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Sale (Full) $1,001 - $15,000
Jul 02, 2025 Jun 03, 2025 -0.48%
Congress pfp
Josh Gottheimer D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Jul 16, 2025 Jun 03, 2025 -0.48%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Jun 06, 2025 May 30, 2025 -2.32%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Jun 10, 2025 May 28, 2025 -1.22%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $15,001 - $50,000
Jun 10, 2025 May 19, 2025 +0.89%
Congress pfp
Robert Bresnahan R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
May 31, 2025 May 15, 2025 +1.98%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 19, 2025 May 14, 2025 +5.57%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $15,001 - $50,000
Jun 22, 2025 May 12, 2025 -0.37%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 06, 2025 May 05, 2025 -6.13%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
May 06, 2025 Apr 29, 2025 -10.38%
Congress pfp
Bruce Westerman R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
May 12, 2025 Apr 21, 2025 -11.11%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -15.10%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -15.10%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc
Sale (Full) $15,001 - $50,000
May 15, 2025 Apr 15, 2025 -16.95%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Sale $15,001 - $50,000
May 12, 2025 Apr 15, 2025 -7.72%
Congress pfp
Jefferson Shreve R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $15,001 - $50,000
May 08, 2025 Apr 11, 2025 -5.92%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
May 08, 2025 Apr 11, 2025 -14.54%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 09, 2025 -14.33%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Sale $15,001 - $50,000
May 12, 2025 Apr 09, 2025 -6.79%
Congress pfp
Robert Bresnahan R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
May 08, 2025 Apr 08, 2025 -21.14%
Congress pfp
Robert Bresnahan R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $15,001 - $50,000
Apr 28, 2025 Apr 08, 2025 -14.27%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $15,001 - $50,000
Apr 07, 2025 Mar 31, 2025 -15.69%
Congress pfp
George Whitesides D / House
NVS logo
NVS STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. NOVARTIS AG COMMON STOCK
Sale $100,001 - $250,000
Apr 23, 2025 Mar 24, 2025 -6.13%
Congress pfp
Carol D. Miller R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 10, 2025 -20.06%
Congress pfp
Bruce Westerman R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Apr 16, 2025 Mar 03, 2025 -14.23%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 06, 2025 Feb 26, 2025 -12.90%
Congress pfp
Robert Bresnahan R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Mar 27, 2025 Feb 25, 2025 -14.07%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -9.89%
Congress pfp
Jefferson Shreve R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -13.24%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 19, 2025 -2.18%
Congress pfp
John Boozman R / Senate
PFE logo
PFE Pfizer Inc
Sale (Full) $1,001 - $15,000
Mar 06, 2025 Feb 13, 2025 -7.46%
Congress pfp
Julie Johnson D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Mar 12, 2025 Feb 12, 2025 -7.91%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 24, 2025 -9.41%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 22, 2025 -9.38%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 22, 2025 +4.33%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 17, 2025 -11.96%
Congress pfp
Julie Johnson D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Feb 12, 2025 Jan 15, 2025 -12.52%
Congress pfp
Emily Randall D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +8.63%
Congress pfp
Virginia Foxx R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +4.90%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Sale $15,001 - $50,000
Dec 05, 2024 Nov 15, 2024 -8.47%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Dec 05, 2024 Nov 15, 2024 -3.20%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 13, 2024 -13.50%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 13, 2024 -13.50%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 12, 2024 -6.50%
Congress pfp
Laurel M. Lee R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Nov 21, 2024 Oct 21, 2024 -22.94%
Congress pfp
Greg Landsman D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Nov 14, 2024 Oct 15, 2024 -25.13%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 14, 2024 -16.62%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 11, 2024 -18.53%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Partial) $1,001 - $15,000
Oct 10, 2024 Sep 17, 2024 -22.89%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Oct 04, 2024 Sep 09, 2024 -24.43%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 27, 2024 -26.88%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Sep 04, 2024 Aug 09, 2024 -32.07%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN C�������: OUR BROKER PURCHASED SHARES OF 29 STOCKS IN MY SPOUSE'S ROTH IRA ON 8/7/24 IN ORDER TO REBALANCE THE PORTFOLIO IN ACCORDANCE WITH THE FIRM'S INVESTMENT STRATEGY FOR ACCOUNTS THAT SIZE. HE FAILED TO NOTIFY ME OF THESE TRANSACTIONS AND IT WASN'T DISCOVERED UNTIL I WAS ATTEMPTING TO RECONCILE OUR INVESTMENT HOLDINGS FOR MY 2024 FINANCIAL DISCLOSURE. SP AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 03, 2025 Aug 07, 2024 -26.72%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $50,001 - $100,000
Aug 20, 2024 Aug 07, 2024 -26.72%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $15,001 - $50,000
Aug 20, 2024 Aug 06, 2024 -36.75%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -29.51%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2024 Aug 02, 2024 -29.51%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -29.51%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Aug 20, 2024 Aug 01, 2024 -35.77%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 -19.50%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -19.50%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Jun 05, 2024 May 29, 2024 -19.82%
Congress pfp
Ro Khanna D / House
PFE logo
PFE DC PFIZER INC. CMN
Purchase $15,001 - $50,000
Jun 05, 2024 May 29, 2024 -31.32%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Sale (Full) $15,001 - $50,000
Jun 14, 2024 May 03, 2024 -34.76%
Congress pfp
Ro Khanna D / House
PFE logo
PFE EPFIZER INC. CMN
None $15,001 - $50,000
May 06, 2024 Apr 26, 2024 -27.14%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
May 06, 2024 Apr 23, 2024 -31.14%
Congress pfp
Sheldon Whitehouse D / Senate
NVS logo
NVS Novartis Ag ADR
Sale (Partial) $1,001 - $15,000
May 20, 2024 Apr 09, 2024 -1.63%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Apr 05, 2024 Mar 25, 2024 -31.50%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $15,001 - $50,000
Apr 05, 2024 Mar 20, 2024 -31.91%
Congress pfp
Ro Khanna D / House
NVS logo
NVS NOVARTIS AG-ADR SPONSORED ADR CMN
Exchange None
Mar 06, 2024 Mar 05, 2024 -
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Jun 12, 2024 Mar 04, 2024 -28.01%
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Jun 12, 2024 Mar 01, 2024 -30.35%
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Jun 12, 2024 Mar 01, 2024 -30.35%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Purchase $1,001 - $15,000
Mar 15, 2024 Feb 27, 2024 -32.82%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Sale $15,001 - $50,000
Mar 06, 2024 Feb 13, 2024 -36.35%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PRZER INC. CMN
Purchase $15,001 - $50,000
Mar 06, 2024 Feb 13, 2024 -36.35%
Congress pfp
Earl Blumenauer D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 02, 2024 Feb 12, 2024 -36.82%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Sale $15,001 - $50,000
Feb 05, 2024 Feb 02, 2024 -36.13%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Feb 05, 2024 Jan 31, 2024 -39.63%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Feb 05, 2024 Jan 31, 2024 -39.63%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -34.35%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -34.38%
Congress pfp
Michael C. Burgess R / House
AMGN logo
AMGN AMGEN INC.
Sale $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -33.81%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 22, 2024 Dec 28, 2023 -46.73%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 22, 2024 Dec 28, 2023 -46.73%
Congress pfp
John Boozman R / Senate
PFE logo
PFE Pfizer Inc
Purchase $1,001 - $15,000
Jan 08, 2024 Dec 20, 2023 -45.58%
Congress pfp
Shelley Moore Capito R / Senate
PFE logo
PFE Pfizer Inc
Sale (Partial) $1,001 - $15,000
Jan 12, 2024 Dec 18, 2023 -42.03%
Congress pfp
Jerry Moran R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Sale (Full) $1,001 - $15,000
Jan 17, 2024 Dec 14, 2023 -39.36%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 12, 2024 Dec 12, 2023 -49.60%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $15,001 - $50,000
Jan 12, 2024 Dec 12, 2023 -49.60%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 12, 2024 Dec 12, 2023 -49.60%
Congress pfp
Sheldon Whitehouse D / Senate
PFE logo
PFE Pfizer Inc
Sale (Full) $1,001 - $15,000
Jan 18, 2024 Dec 11, 2023 -50.45%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Jan 04, 2024 Dec 05, 2023 -53.37%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $15,001 - $50,000
Jan 04, 2024 Dec 04, 2023 -53.87%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Dec 06, 2023 Nov 28, 2023 -55.58%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Dec 06, 2023 Nov 21, 2023 -57.81%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Dec 06, 2023 Nov 17, 2023 -57.46%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $15,001 - $50,000
Dec 06, 2023 Nov 03, 2023 -66.15%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -41.48%
Congress pfp
Greg Stanton D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -67.82%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Sale $50,001 - $100,000
Nov 08, 2023 Oct 10, 2023 -70.73%
Congress pfp
Ro Khanna D / House
PFE logo
PFE (PFIZER INC. CMN
Sale $15,001 - $50,000
Nov 08, 2023 Oct 02, 2023 -74.82%
Congress pfp
Greg Stanton D / House
PFE logo
PFE PFIZER, INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -71.36%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -37.33%
Congress pfp
Sheldon Whitehouse D / Senate
NVS logo
NVS Novartis Ag ADR
Purchase $15,001 - $50,000
Oct 17, 2023 Sep 20, 2023 -32.31%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Oct 12, 2023 Sep 11, 2023 -67.90%
Congress pfp
Lois Frankel D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Oct 10, 2023 Sep 08, 2023 -69.48%
Congress pfp
Ro Khanna D / House
PFE logo
PFE IPFIZER INC. CMN
Purchase $50,001 - $100,000
Oct 06, 2023 Sep 06, 2023 -69.50%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Aug 21, 2024 Sep 01, 2023 -70.72%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Purchase $1,001 - $15,000
Sep 06, 2023 Aug 29, 2023 -72.12%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Sale $15,001 - $50,000
Sep 06, 2023 Aug 03, 2023 -69.98%
Congress pfp
Ro Khanna D / House
PFE logo
PFE PFIZER INC. CMN
Sale $1,001 - $15,000
Aug 07, 2023 Jul 28, 2023 -69.56%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Purchase $1,001 - $15,000
Aug 14, 2023 Jul 25, 2023 -71.81%